In The News Posted October 7, 2021 Share Posted October 7, 2021 BRANFORD, Conn., Oct. 7, 2021 /PRNewswire/ -- IsoPlexis Corporation ("IsoPlexis"), a leader in functional single-cell proteomics, today announced the pricing of its initial public offering of 8,333,000 shares of common stock at a public offering price of $15.00 per share. All of the...View the full article Quote Link to comment Share on other sites More sharing options...
Recommended Posts